Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state. 1993

M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
Department of Cardiology, University Hospital, Groningen, The Netherlands.

OBJECTIVE To determine the relation between functional capacity and heart rate response to exercise in patients with atrial fibrillation. METHODS 73 consecutive patients with chronic atrial fibrillation. METHODS Relation between functional capacity, measured as peak oxygen consumption (peak VO2; ml/min/kg), and heart rate at all stages of exercise in univariate and multivariate analyses. RESULTS Peak VO2 showed no correlation with resting heart rate, but it showed a negative correlation with heart rate during the first stage of exercise (r = -0.94, p < 0.01). Indeed, heart rate during the early stages of exercise (stages 1-5) was higher in patients with a peak VO2 less than or equal to 20 ml/mm/kg than in those with a peak VO2 greater than 20 ml/min/kg (heart rate 140 v 125 beats/min, p < 0.05). At maximal exercise, however, peak VO2 was positively correlated with heart rate (r = 2.15, p < 0.0001). CONCLUSIONS In patients with atrial fibrillation and impaired functional capacity heart rate at low levels of exercise is augmented but maximal heart rate attenuated compared with patients with preserved functional capacity. Excessive heart rate responses to minor exercise may have deleterious effects on left ventricular function and thereby further limit functional capacity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
February 1990, Pacing and clinical electrophysiology : PACE,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
October 2005, International journal of cardiology,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
July 2000, Japanese heart journal,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
April 2004, Circulation journal : official journal of the Japanese Circulation Society,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
June 2009, The American journal of cardiology,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
November 2016, JACC. Clinical electrophysiology,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
July 2021, Heart, lung & circulation,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
January 2003, Japanese heart journal,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
May 1983, Pacing and clinical electrophysiology : PACE,
M P van den Berg, and H J Crijns, and A T Gosselink, and S A van den Broek, and H J Hillege, and D J van Veldhuisen, and K I Lie
September 1972, Kardiologiia,
Copied contents to your clipboard!